JPS61113463A - Circuit and method for serum operation system - Google Patents

Circuit and method for serum operation system

Info

Publication number
JPS61113463A
JPS61113463A JP59234564A JP23456484A JPS61113463A JP S61113463 A JPS61113463 A JP S61113463A JP 59234564 A JP59234564 A JP 59234564A JP 23456484 A JP23456484 A JP 23456484A JP S61113463 A JPS61113463 A JP S61113463A
Authority
JP
Japan
Prior art keywords
plasma
blood
membrane
processing circuit
separation device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP59234564A
Other languages
Japanese (ja)
Inventor
木下 嘉清
大西 道一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Priority to JP59234564A priority Critical patent/JPS61113463A/en
Publication of JPS61113463A publication Critical patent/JPS61113463A/en
Pending legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。
(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.

Description

【発明の詳細な説明】 (用語の説明) 本明−書中において、血漿とは血液中の液状成分のこと
とし、血球とは、血液から血漿の全部または一部を取り
除いた、赤血球、白血球、血小板等の有形成分または有
形成分を含む血液の一部分とする。また、血漿処理とは
、有害物質や不要成分の除去、薬効物質の添加、不足成
分の補充等の処理を血漿に施すことばかりでなく、血漿
を補液または他、の血漿と置換する等の処理を行なうこ
とをもふくめるものとする。
Detailed Description of the Invention (Explanation of Terms) In this specification, plasma refers to a liquid component in blood, and blood cells refer to red blood cells and white blood cells from which all or part of plasma has been removed. , formed components such as platelets, or a portion of blood containing formed components. In addition, plasma processing refers not only to the removal of harmful substances and unnecessary components, the addition of medicinal substances, and the replenishment of deficient components to plasma, but also the treatment of plasma with fluid replacement or replacement with other plasma. It shall also include carrying out.

イ3発明の目的 、(産業上の利用分野) 、疾患の中には、血漿処理を施すことにより、その症状
を緩和したり治癒させたり出来るものかある0例えば、
薬物中毒、劇症肝炎、マクログロブリン症、高脂血症、
多発性骨髄症、重症筋無力症の6疾患は健康保険適用疾
患として血漿処理を通用した治療が認められている。上
記の疾患の他にも、リウマチ性関節炎、肝不全、エリテ
マトーデス、腎炎等長(の症例に対する通用例、有効例
が報告されている。
B3 Purpose of the invention (industrial application field) Some diseases can be alleviated or cured by plasma treatment. For example,
drug addiction, fulminant hepatitis, macroglobulinosis, hyperlipidemia,
Six diseases, including multiple myelopathy and myasthenia gravis, are eligible for treatment through plasma processing as covered by health insurance. In addition to the above-mentioned diseases, common and effective cases have been reported for rheumatoid arthritis, liver failure, lupus erythematosus, and nephritis.

本発明は、これらの疾患をふくむ様々な疾患の治療を行
なうことを目的とし、患者から採血した血液を血漿と血
球とに分離し、血漿処理を施し、再び血漿を血球と混合
して患者に返血する、という一連の工程からなる血漿操
作を行なうための、血漿操作システム用回路及び血gI
t操作方法に関するものである。
The purpose of the present invention is to treat various diseases including these diseases, and the present invention separates blood collected from a patient into plasma and blood cells, performs plasma processing, mixes the plasma with blood cells again, and then administers the blood to the patient. Plasma manipulation system circuit and blood gI for performing plasma manipulation consisting of a series of steps of returning blood.
t operation method.

(従来の技術) 前記疾患を持った患者に、血漿処理による治療!   
      を施す場合ゝ用2゛て6゛た従来″l操作
’yl−r”用回路を、第91m (a)に示す。
(Prior art) Treatment of patients with the above-mentioned diseases using plasma treatment!
A circuit for the conventional ``l operation ``yl-r'' which is used for ``2'' and 6'' is shown in No. 91m (a).

従来の血漿操作システム用回路は、人体から血液を採取
する採血部1、適正な採血圧に維持する血液ポンプ2及
び採血正異常検出器3、回路の潅流中に血液が凝固する
のを抑止する抗凝血剤の注入機構4、採血された血液を
血漿と血球とに分離する機能を持った腹式血漿分離装置
50、分離された血漿の処理機能域6と該血漿の流量を
調節する血漿ポンプ7と血漿中に血球が混入するのを防
止するための漏血検出装置8とを備え腹式血漿分離装置
5に連接された血漿処理回路9、血液温度を適温にする
ヒーター10、適所に設けた血液中または血漿中の気泡
を脱気するドリップチャンバー11、血液中に気泡が混
入するのを防止するための気泡検出装置12、流路内の
血圧又は血漿圧を測定する圧力計13、処理された血漿
と護式血漿分離装置5から流出する血球との混合部30
、混合された血液を人体へ返血する返血部14、等から
なる。
A conventional circuit for a plasma manipulation system includes a blood sampling unit 1 that collects blood from a human body, a blood pump 2 that maintains an appropriate blood sampling pressure, a blood sampling normality/abnormality detector 3, and a blood sampling unit that prevents blood from coagulating during perfusion of the circuit. An anticoagulant injection mechanism 4, an abdominal plasma separator 50 that has the function of separating collected blood into plasma and blood cells, a separated plasma processing function area 6, and a plasma that adjusts the flow rate of the plasma. A plasma processing circuit 9 that includes a pump 7 and a blood leakage detection device 8 for preventing blood cells from getting mixed into the plasma, and is connected to the abdominal plasma separator 5, a heater 10 that adjusts the blood temperature to an appropriate temperature, and a A drip chamber 11 for deaerating air bubbles in the blood or plasma provided therein, a bubble detection device 12 for preventing air bubbles from being mixed into the blood, a pressure gauge 13 for measuring blood pressure or plasma pressure in the flow path, Mixing section 30 for the treated plasma and blood cells flowing out from the protective plasma separator 5
, a blood return unit 14 that returns the mixed blood to the human body, and the like.

患者から採血された血液はドリップチャンバー11等の
脱気装置を経て腹式血漿分離装置50へ送られ、血漿と
血球とに分離される0分離された血漿       1
は、血漿処理回路9に導かれて所要の処理を施された後
、混合部30で腹式血漿分離装置50から流出する血球
と混合され、返血部14より人体へ戻る。
Blood collected from a patient is sent to an abdominal plasma separator 50 through a degassing device such as a drip chamber 11, where it is separated into plasma and blood cells.
After being led to the plasma processing circuit 9 and subjected to necessary processing, it is mixed with blood cells flowing out from the abdominal plasma separator 50 in the mixing section 30, and returned to the human body through the blood return section 14.

(発明が解決しようとする問題点) ところで、この様な回路構成では、血漿分離圧が過大と
なった場合に目詰まりが生じ易く、これを解決するため
に本出願人は特願昭58−145590号において第9
図(b)に示した様な回路構成を提案した。
(Problems to be Solved by the Invention) By the way, in such a circuit configuration, clogging is likely to occur when the plasma separation pressure becomes excessive. No. 9 in No. 145590
We proposed a circuit configuration as shown in Figure (b).

前記特願昭58−145590号に係る回路構成による
血液操作は、前述した分離工程と混合工程とを、血液を
血漿と血球とに分離する機能のほか分離された血漿と血
球とを混合する機能をも併せ持った膜式血漿離合装置5
で行うことをその主点としている。
Blood manipulation using the circuit configuration according to Japanese Patent Application No. 58-145590 includes the above-mentioned separation step and mixing step, in addition to the function of separating blood into plasma and blood cells, the function of mixing separated plasma and blood cells. Membrane plasma separation device 5
The main point is to do it in

前記回路中で用いられている膜式血漿離合装置5の構成
を、第10図に基づ(、’s”i説明する。該膜式血漿
離合装W15は、両端面一血液の流入口15a及び流出
口15b、側壁に分離された血漿の送出口16a及び回
帰口16bが設けられた外筒体17と、両端をポリウレ
タン系樹脂などの樹脂層18で前記外″筒体17の内部
に固着された中空糸19とから成る。前記樹脂層18に
より、膜式血漿離合装置5の内部は、血液の流入部20
a及び流出部20bと、血漿離合部21とに区画されて
いる。前記中空糸19は、血球に対して不透過性を有す
る半透膜を中空の繊維状に成形したものであり、その孔
径は0.01〜5μmが好ましい。
The configuration of the membrane plasma separation device 5 used in the circuit will be explained based on FIG. and an outer cylindrical body 17 provided with an outflow port 15b, a discharge port 16a for separated plasma, and a return port 16b on the side wall, and both ends fixed to the inside of the outer cylinder 17 with a resin layer 18 such as a polyurethane resin. The resin layer 18 allows the inside of the membrane plasma separation device 5 to form a blood inflow section 20.
It is divided into an outflow section a, an outflow section 20b, and a plasma separation section 21. The hollow fibers 19 are formed by molding a semipermeable membrane impermeable to blood cells into a hollow fiber shape, and preferably have a pore diameter of 0.01 to 5 μm.

血液は膜式血漿離合装置5の流入口15aから入り中空
糸19の一本一本の内部を流れる。血液が中空糸19の
内部を通過する最中に、半透膜である中空糸19の膜壁
から血漿が分離浸出する0分離された血漿は、膜式血漿
離合装置5の側壁に設けられた送出口16aから血漿処
理回路へ導かれ、所定の血漿処理がなされた後、膜式血
漿離合装置5に回帰する。処理された血漿は、回帰口1
6bより血漿離合部21に流入し、中空糸19の外面か
らその内部に浸透することにより血球と混合される。
Blood enters from the inlet 15a of the membrane plasma separation device 5 and flows inside each hollow fiber 19. While blood passes through the inside of the hollow fiber 19, plasma is separated and leached from the membrane wall of the hollow fiber 19, which is a semipermeable membrane. The plasma is guided from the outlet 16a to the plasma processing circuit, and after being subjected to a predetermined plasma processing, returns to the membrane plasma separation device 5. The processed plasma is transferred to the return port 1.
6b, it flows into the plasma separation section 21, penetrates into the interior of the hollow fiber 19 from the outer surface, and is mixed with blood cells.

ところで、前記特願昭58−145590号に係る回路
構成による血漿操作の実行中は、腹式血漿離合装置5内
の中空糸19の各々について、その膜壁が血液から血漿
を分離する領域と血漿を血球と混合する領域とに分かれ
る。血液から血漿を分離する側の領域では、流れが常に
中空糸の内部から外方に向かう方向となっているので、
第9図(a)に示した、従来の回路構成よりは目詰まり
が生じに(いとはいえ、−変性じた目詰まりは自然には
解消し難く、むしろ進行する状態となるので、血漿が分
離、混合される効率が恒常的に低下すると同時に、血漿
の分離と混合との間に不均衡が生ずるという懸念があっ
た。
By the way, during execution of plasma manipulation using the circuit configuration according to the above-mentioned Japanese Patent Application No. 58-145590, the membrane wall of each hollow fiber 19 in the abdominal plasma separation device 5 separates the area where plasma from blood is separated from the plasma. It is divided into a region where it mixes with blood cells and a region where it mixes with blood cells. In the area where plasma is separated from blood, the flow is always from the inside of the hollow fiber to the outside.
As shown in Figure 9(a), clogging is more likely to occur than in the conventional circuit configuration. There was a concern that the efficiency of separation and mixing would be permanently reduced and at the same time an imbalance would occur between plasma separation and mixing.

口0発明の構成 (問題点を解決するための手段及びその作用)血漿操作
システム用回路の血漿処理回路に、膜式血漿離合装置に
依って分離された血漿を蓄積するための貯血類機構と、
膜式血漿離合装置と血漿処理回路との間の血漿の流れを
一方向に制御する流路制御手段とを設け、血液から血漿
を分離する工程と、血漿を血球と混合する工程とを、交
互にL      繰り返し行なうこととした。依って
、血漿が、膜式血漿離合装置から血漿処理回路へ流出す
る状態と、血漿処理回路から膜式血漿離合装置へ回帰す
る状態とが、繰り返し交替することになる。
Structure of the Invention (Means for Solving the Problems and Their Effects) A blood storage mechanism for accumulating plasma separated by a membrane plasma separation device in the plasma processing circuit of the plasma processing system circuit. ,
A flow path control means for controlling the flow of plasma in one direction between the membrane plasma separation device and the plasma processing circuit is provided, and the process of separating plasma from blood and the process of mixing plasma with blood cells are alternately performed. I decided to do this repeatedly. Therefore, the state in which plasma flows out from the membrane plasma separation device to the plasma processing circuit and the state in which plasma returns from the plasma processing circuit to the membrane plasma separation device are alternated repeatedly.

(実施例) 本発明に係る血漿操作システム用回路及び血漿操作方法
を、高脂血症、高コレステロール血症、動脈硬化症等の
原因とされている血漿中の低密度リポ蛋白質及び極低密
度リポ蛋白質(以下LDLと略す)の除去に適用した場
合について説明する。
(Example) The circuit for a plasma manipulation system and the plasma manipulation method according to the present invention were applied to low-density lipoproteins and extremely low-density lipoproteins in plasma, which are considered to be the cause of hyperlipidemia, hypercholesterolemia, arteriosclerosis, etc. A case where the present invention is applied to the removal of lipoproteins (hereinafter abbreviated as LDL) will be explained.

第1図に、本発明に係る血漿操作システム用回路の要部
を模式的に示す。
FIG. 1 schematically shows the main parts of a circuit for a plasma manipulation system according to the present invention.

膜式血漿離合装置5に連接された血漿処理回路31は、
処理機能域に設けられたLDL除去装置32と、血漿を
蓄積するための貯血類機構33と、流路の適所に設けら
れた流路制御手段34とを備え、その他に、血球が血漿
に混入するのを防止するための漏血検出装置8、血漿処
理回路中の血漿の流量を調節する血漿ポンプ7、血漿中
の気泡を脱気するドリップチャンバー11、流路内の血
圧または血漿圧を測定する圧力計13等が適宜配設され
ている。
The plasma processing circuit 31 connected to the membrane plasma separation device 5 includes:
It is equipped with an LDL removal device 32 provided in the processing function area, a blood storage mechanism 33 for accumulating plasma, and a flow path control means 34 provided at an appropriate location in the flow path, and also includes an LDL removal device 32 provided in the processing function area, and a flow path control means 34 provided at an appropriate location in the flow path. A blood leakage detection device 8 to prevent blood leakage, a plasma pump 7 to adjust the flow rate of plasma in the plasma processing circuit, a drip chamber 11 to degas bubbles in the plasma, and a blood pressure or plasma pressure in the flow path to be measured. A pressure gauge 13 and the like are appropriately arranged.

本発明に係る血漿操作システム用回路に用いる膜式血漿
離合装置5は、側壁に血漿の送出口及び回帰口がそれぞ
れ設けられているが、これを−個の開孔によって兼用す
ることも出来る。
The membrane-type plasma separation device 5 used in the circuit for the plasma manipulation system according to the present invention has a plasma outlet and a return port respectively provided on the side wall, but these can also be used as two openings.

本実施例に用いるLDL除去装置32とは、血漿中のL
DLを選択的に吸着する吸着剤が充填されたカラム、L
DLの濾過膜、正常血漿との置換装置等のことである。
The LDL removal device 32 used in this example is a device for removing L in plasma.
A column packed with an adsorbent that selectively adsorbs DL, L
This refers to DL filter membranes, normal plasma replacement equipment, etc.

また血漿を逐次蓄積するための貯血類機構33とはミ外
気との疎通がない密閉された容量可変性の容器であって
、蓄積された血漿を残さずに放出できるものであればよ
い、それには、例えば、第5図・に示したシリンジ35
を蛇腹状の外殻体36で被覆した機構、第6図(A)、
  (B)に示した流出口と流入口とを有する袋体、ま
たは、第7図に示した伸縮性のある流出口と流入口とを
有する袋体、さらに、第8図(イ)、(ロ)に示した流
入口37aと流出口37bとを有する袋体38と、圧迫
ローラ39と被圧壁40のような該袋体3Bに蓄積され
た血漿の圧出手段とを設けた機構等がある。
The blood storage mechanism 33 for sequentially accumulating plasma may be a closed container with a variable capacity that has no communication with the outside air, and can discharge the accumulated plasma without leaving it behind. For example, the syringe 35 shown in FIG.
6(A), a mechanism in which a bellows-shaped outer shell 36 covers the
A bag body having an outflow port and an inflow port shown in (B), or a bag body having a stretchable outflow port and an inflow port shown in FIG. A mechanism including a bag body 38 having an inlet port 37a and an outlet port 37b shown in b), and means for pumping out the plasma accumulated in the bag body 3B, such as a pressure roller 39 and a pressure-receiving wall 40, etc. There is.

本実施例に用いる流路制御手段34とは、鉗子、ピンチ
パルプ、仕切弁、コック、等適宜の流路開閉手段である
The flow path control means 34 used in this embodiment is an appropriate flow path opening/closing means such as forceps, pinch pulp, gate valve, cock, etc.

本発明に係る血漿操作方法を以下に述べる。The plasma manipulation method according to the present invention will be described below.

患者から採血された血液をドリップチャンバー等の脱気
装置を経て膜式血漿離合装置5に送る。
Blood collected from a patient is sent to the membrane plasma separation device 5 through a degassing device such as a drip chamber.

血漿が血漿処理回路31から膜式血漿離合装置5へ回帰
する流路を閉止し、膜式血漿離合装置5から血漿処理回
路31へ流出する流路を開放することによって膜式血漿
離合装置5は血漿の分離のみを行なう0分離された血漿
成分を、血漿ポンプ7によって膜式血漿離合装置側壁の
送出口16aから血漿処理回路31に設けられた貯血類
機構33に送出し逐次蓄積する。血漿を貯血類機構33
に所定量蓄積する間、貯血類機構33の放出口は閉止す
る。
The membrane plasma separation device 5 can be operated by closing the flow path through which plasma returns from the plasma processing circuit 31 to the membrane plasma separation device 5 and opening the flow path through which plasma flows out from the membrane plasma separation device 5 to the plasma processing circuit 31. Separated plasma components, which perform only plasma separation, are delivered by the plasma pump 7 from the delivery port 16a on the side wall of the membrane plasma separator to the blood storage mechanism 33 provided in the plasma processing circuit 31, where they are sequentially accumulated. Blood plasma storage mechanism 33
The discharge port of the blood storage mechanism 33 is closed while a predetermined amount of blood is accumulated.

血漿が所定量蓄積されたら、貯血類機構33の流入口及
び血漿が膜式血漿離合装置5から血漿処理回路31へ流
出する流路を閉止し、血漿が血漿処理回路31から膜式
血漿離合装25へ回帰する流路は開放して血漿ポンプ7
によって所定流速度でLDL除去装置32へ血漿を移送
する。LDL除去装置32で処理した後、血漿を膜式血
漿離合装置5に回帰させる。血漿は、外表面から中空糸
の内部へ浸透して血球と混合され、やがて人体へ戻る。
When a predetermined amount of plasma has been accumulated, the inlet of the blood storage mechanism 33 and the flow path through which plasma flows out from the membrane plasma separation device 5 to the plasma processing circuit 31 are closed, and the plasma flows from the plasma processing circuit 31 to the membrane plasma separation device. The flow path returning to 25 is opened and the plasma pump 7
The plasma is transferred to the LDL removal device 32 at a predetermined flow rate. After being processed in the LDL removal device 32, the plasma is returned to the membrane plasma separation device 5. Plasma penetrates from the outer surface into the interior of the hollow fiber, mixes with blood cells, and eventually returns to the human body.

貯血5i機+R33を設ける位置は、第2図に示したよ
うに、LDL除去装置32の下流側に設けてもよい、こ
の場合には、膜式血漿離合装置5によって分離された血
漿は、まずLDL除去装置32で処理された後、貯血及
機構33に蓄積されることになる。
The blood storage 5i machine +R33 may be installed downstream of the LDL removal device 32 as shown in FIG. 2. In this case, the plasma separated by the membrane plasma separation device 5 is first After being processed by the LDL removal device 32, it is stored in the blood storage mechanism 33.

さらに、貯血WkII!A構33は一個に留まらず複数
個を設けることも可能である。すなわち第3図に示した
ように、血51操作システム用回路内に膜式血漿離合装
置5及び貯血崇機構33をそれぞれ二個ずつ設け、−個
のLDL除去装置32を共通とする、貯血棄機構33を
備えた血漿処理回路が二個の膜式血WILIl1合装W
5のそれぞれに連接されている。一方の血漿処理回路を
血漿の分離及び蓄積に使用している時には、他方の血漿
処理回路には蓄積された血漿の放出及び混合を行なわせ
、これを交互に繰り返す、このような血漿処理方法を採
用することによって、LDL除去装置は常時稼動するこ
とになり、血漿から所定量のLDLを除去するのに必要
な時間を短縮できる。
Furthermore, blood storage WkII! The number of A structures 33 is not limited to one, but it is also possible to provide a plurality of A structures. That is, as shown in FIG. 3, two membrane-type plasma separation devices 5 and two blood storage mechanisms 33 are provided in the circuit for the blood 51 operation system, and - LDL removal devices 32 are used in common. A plasma processing circuit equipped with a mechanism 33 is a combination of two membrane-type blood cells.
5 are connected to each other. When one plasma processing circuit is used for plasma separation and accumulation, the other plasma processing circuit is used to release and mix the accumulated plasma, and this process is repeated alternately. By employing this method, the LDL removal device will be in constant operation, and the time required to remove a predetermined amount of LDL from plasma can be shortened.

また、血漿を蓄積する場合にも、貯血及機構から放出す
る場合にも、LDL除去装置を経由させることにより、
LDLの除去効率を高めることが可能である。すなわち
第4図に示した如く、血漿処理回路31において、LD
L除去装置32の下流側と貯血及機構33の流入口とを
繋ぐ流路及び貯血及機構33の流出口とLDL除去装置
32の流入口とを繋ぐ流路を設けた血漿操作システム用
回路を用いることにより、膜式血漿離合装置5で分離さ
れた血漿をまずLDL除去装置32を通過させて一時貯
血漿機構33に蓄積する。所定量が蓄積されれば、昇び
血漿をLDL除去装置32を通過させて膜式血漿離合装
置5へ回帰させ、血球と混合する。この方法によれば、
分離された血漿は2度LDL除去装置32を通過するの
賜、LDLの除去効率が向上する。
In addition, both when storing plasma and when releasing it from the blood storage mechanism, by passing it through the LDL removal device,
It is possible to increase the removal efficiency of LDL. That is, as shown in FIG. 4, in the plasma processing circuit 31, the LD
A circuit for a plasma manipulation system is provided with a flow path connecting the downstream side of the L removal device 32 and the inlet of the blood storage mechanism 33 and a flow path connecting the outlet of the blood storage mechanism 33 and the inlet of the LDL removal device 32. By using this, plasma separated by the membrane plasma separation device 5 first passes through the LDL removal device 32 and is temporarily accumulated in the plasma storage mechanism 33. When a predetermined amount is accumulated, the elevated plasma is passed through the LDL removal device 32 and returned to the membrane plasma separation device 5, where it is mixed with blood cells. According to this method,
Since the separated plasma passes through the LDL removal device 32 twice, the LDL removal efficiency is improved.

ハ1発明の効果                  
    豐本発明に係る血漿操作システム用回路及び血
漿操作方法を用いることにより、血液から血漿を分離す
る工程と分離された血漿を血球と混合する工程とを交互
に行なうので、膜式血漿離合装置内の中空糸の膜壁を横
切る血漿の流れの向きが、分離工程時と混合工程時とで
交替する。従って、中空糸膜壁の微小孔に目詰まりが生
じにくり、仮に目詰まりが生じた場合でも、血漿の流れ
る向きが交替することによって目詰まりが解消される。
C1 Effects of the invention
豐By using the circuit for a plasma manipulation system and the plasma manipulation method according to the present invention, the step of separating plasma from blood and the step of mixing separated plasma with blood cells are performed alternately, so that the process of separating plasma from blood and mixing the separated plasma with blood cells are performed alternately. The direction of the flow of plasma across the membrane wall of the hollow fibers changes during the separation process and during the mixing process. Therefore, the micropores in the hollow fiber membrane wall are less likely to be clogged, and even if clogging occurs, the flow direction of the plasma is changed, thereby eliminating the clogging.

依って、中空糸膜壁は血漿の流通が良好な状態に維持さ
れるので、血漿を分離、混合する効率が非常に良くなり
、血漿操作に要する時間が短縮される。
Therefore, the hollow fiber membrane wall maintains a good flow of plasma, so that the efficiency of separating and mixing plasma becomes very high, and the time required for plasma manipulation is shortened.

また、分離工程中は中空糸の全体を分離に使用するので
、低い膜間圧で容易に血漿を分離することが可能となり
、溶血の恐れがなくなる。
Furthermore, since the entire hollow fiber is used for separation during the separation process, plasma can be easily separated with low transmembrane pressure, eliminating the risk of hemolysis.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図乃至第4図は本発明に係る血漿操作システム用回
路の実施態様を模式的に示したものであり、それぞれ、
血液から分離された血漿を逐次蓄積している過程中を示
した、第1の実施例乃至第4の実施例である。第5図乃
至第8図はそれぞれ本発明に係る貯血及機構の実施例を
示したものであり、第5図は蛇腹状の外殻体を有する貯
血及機構の部分断面図、第6図(A)及び(B)は流入
口と流出口とを有する袋体の正面図及び側面図、第7図
は流入口と流出口・とを有する伸縮性のある袋体、第8
図(イ)及び(ロ)は流入口と流出口とを有する袋体と
、圧迫ローラと被圧面とからな・る蓄積された血漿の圧
出手段とからなる貯血及機構の正面図及び側面図である
。第9図(a)は従来の血漿操作システム用回路を示し
た模式図、第9図(b)は特願昭58−145590号
に記載された発明に係る血漿操作システム用回路を示し
た模式図、第10図は膜式血漿離合装置の部分断面図で
ある。 5−膜式血漿離合装置 31−・血漿処理回路32−・
LDL除去装置 33・−・−貯血及機構34・−・流
路制御手段 特許出願人 鐘淵化学工業株式会社 出願代理人 弁理士  内1)敏彦 (ロ) 第8図 (イ)
FIGS. 1 to 4 schematically show embodiments of a circuit for a plasma manipulation system according to the present invention, and respectively show
The first to fourth embodiments show the process of sequentially accumulating plasma separated from blood. 5 to 8 respectively show embodiments of the blood storage mechanism according to the present invention. FIG. 5 is a partial sectional view of the blood storage mechanism having a bellows-shaped outer shell, and FIG. A) and (B) are front and side views of a bag body having an inlet and an outlet; FIG. 7 is a stretchable bag body having an inlet and an outlet;
Figures (a) and (b) are a front view and a side view of a blood storage mechanism consisting of a bag body having an inlet and an outlet, and means for pumping out the accumulated plasma, which is made up of a compression roller and a pressurized surface. It is a diagram. FIG. 9(a) is a schematic diagram showing a conventional circuit for a plasma manipulation system, and FIG. 9(b) is a schematic diagram showing a circuit for a plasma manipulation system according to the invention described in Japanese Patent Application No. 145590/1983. 10 are partial cross-sectional views of the membrane plasma separation device. 5-Membrane plasma separation device 31-・Plasma processing circuit 32-・
LDL removal device 33.--Blood storage and mechanism 34.--Flow path control means Patent applicant Kanebuchi Chemical Industry Co., Ltd. Application agent Patent attorney 1) Toshihiko (B) Figure 8 (A)

Claims (1)

【特許請求の範囲】 1、血液を血漿と血球とに分離する機能のほか分離され
た血漿と血球とを混合する機能をも併せ持った膜式血漿
離合装置と、分離された血漿の処理機能域及び貯血漿機
構を備え膜式血漿離合装置に連接された血漿処理回路と
、膜式血漿離合装置と血漿処理回路との間の血漿の流れ
を一方向に制御する流路制御手段とが設けられた、血漿
操作システム用回路。 2、血漿操作過程中において、血漿が血漿処理回路から
膜式血漿離合装置へ回帰する流路を閉止し膜式血漿離合
装置から血漿処理回路へ流出する流路を開放して膜式血
漿離合装置によって分離された血漿を血漿処理回路に設
けられた貯血漿機構によって逐次蓄積することにより血
液から血漿を分離する工程と、血漿が膜式血漿離合装置
から血漿処理回路へ流出する流路を閉止し血漿処理回路
から膜式血漿離合装置へ回帰する流路を開放して貯血漿
機構に蓄積された血漿を漸次放出することにより血漿を
血球と混合する工程とを、交互に行なうことを特徴とす
る、血漿操作方法。
[Scope of Claims] 1. A membrane-type plasma separation device that has not only the function of separating blood into plasma and blood cells but also the function of mixing the separated plasma and blood cells, and a functional area for processing the separated plasma. and a plasma processing circuit including a plasma storage mechanism and connected to the membrane plasma separation device, and a flow path control means for controlling the flow of plasma in one direction between the membrane plasma separation device and the plasma processing circuit. and circuits for plasma manipulation systems. 2. During the plasma manipulation process, the flow path where plasma returns from the plasma processing circuit to the membrane plasma separator is closed, and the flow path from the membrane plasma separator to the plasma processing circuit is opened and the membrane plasma separator is closed. The step of separating plasma from blood by sequentially accumulating the separated plasma in a plasma storage mechanism provided in the plasma processing circuit, and closing the flow path through which plasma flows from the membrane plasma separation device to the plasma processing circuit. It is characterized by alternately performing the step of mixing plasma with blood cells by opening the flow path returning from the plasma processing circuit to the membrane plasma separation device and gradually releasing the plasma accumulated in the plasma storage mechanism. , plasma manipulation methods.
JP59234564A 1984-11-07 1984-11-07 Circuit and method for serum operation system Pending JPS61113463A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59234564A JPS61113463A (en) 1984-11-07 1984-11-07 Circuit and method for serum operation system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59234564A JPS61113463A (en) 1984-11-07 1984-11-07 Circuit and method for serum operation system

Publications (1)

Publication Number Publication Date
JPS61113463A true JPS61113463A (en) 1986-05-31

Family

ID=16972989

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59234564A Pending JPS61113463A (en) 1984-11-07 1984-11-07 Circuit and method for serum operation system

Country Status (1)

Country Link
JP (1) JPS61113463A (en)

Similar Documents

Publication Publication Date Title
US5439587A (en) Self priming filter apparatus
JP4173969B2 (en) Hemodialysis filter and hemodiafiltration device
US4600512A (en) Reverse osmosis water purification module
EP2586474B1 (en) Hemodialysis device
CA1054073A (en) Gas purging fluid filter
KR100649260B1 (en) Dual-stage filtration cartridge
JPS61119271A (en) Blood component treatment circuit and method
JP4050808B2 (en) Composite device for extracorporeal circuit comprising venous blood reservoir and cardiotomy blood reservoir
EP0909188A1 (en) Blood treatment system
EP3782672B1 (en) Pressure detector
US20210052797A1 (en) Pressure Detector
JPH0857043A (en) Blood purifying device
JPS61113463A (en) Circuit and method for serum operation system
EP3603697A1 (en) Blood purification device and method for controlling same
JP6245706B2 (en) Blood purification apparatus and blood purification system
EP3407932B1 (en) Filter for purifying blood
JP4297767B2 (en) Blood processing filter system
JP2799179B2 (en) Liquid processor
JP6745027B2 (en) Device for removing microbubbles in blood and cardiopulmonary system
JP6736744B2 (en) Blood purification device and blood purification system
WO2023070275A1 (en) Air trap device for hemodialysis, corresponding set for hemodialysis and corresponding methods for operating air trap device
JP6736745B2 (en) Blood purification device and blood purification system
JP4337980B2 (en) Blood purification equipment
JP2755966B2 (en) Blood processing equipment
JP3257998B2 (en) Hollow fiber membrane dialyzer